Several studies have linked protein carbamylation with adverse outcomes — including erythropoietin resistance, heart failure, and mortality in ESRD (24–27) — and increased risk of CKD progression in a pilot study of 150 participants from the CRIC Study (28). Here, EPO is linked to chronic kidney disease.